nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—Electrocardiogram ST segment depression—Varenicline—nicotine dependence	0.0372	0.0892	CcSEcCtD
Propofol—Fospropofol—GABRA4—nicotine dependence	0.0297	1	CrCbGaD
Propofol—Withdrawal symptom—Varenicline—nicotine dependence	0.0206	0.0494	CcSEcCtD
Propofol—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.0172	0.0413	CcSEcCtD
Propofol—Throat irritation—Varenicline—nicotine dependence	0.0167	0.0401	CcSEcCtD
Propofol—Urine abnormality—Varenicline—nicotine dependence	0.0153	0.0366	CcSEcCtD
Propofol—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0129	0.0309	CcSEcCtD
Propofol—Thrombosis—Varenicline—nicotine dependence	0.0119	0.0286	CcSEcCtD
Propofol—Nystagmus—Varenicline—nicotine dependence	0.0118	0.0284	CcSEcCtD
Propofol—Hyperlipidaemia—Varenicline—nicotine dependence	0.0117	0.0281	CcSEcCtD
Propofol—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00935	0.0224	CcSEcCtD
Propofol—Thinking abnormal—Varenicline—nicotine dependence	0.00923	0.0221	CcSEcCtD
Propofol—Leukocytosis—Varenicline—nicotine dependence	0.00899	0.0216	CcSEcCtD
Propofol—Abnormal dreams—Varenicline—nicotine dependence	0.00835	0.02	CcSEcCtD
Propofol—Hyperkalaemia—Varenicline—nicotine dependence	0.0083	0.0199	CcSEcCtD
Propofol—Salivary hypersecretion—Varenicline—nicotine dependence	0.0082	0.0197	CcSEcCtD
Propofol—Hypertonia—Varenicline—nicotine dependence	0.0074	0.0178	CcSEcCtD
Propofol—Mental disability—Varenicline—nicotine dependence	0.00733	0.0176	CcSEcCtD
Propofol—Euphoric mood—Varenicline—nicotine dependence	0.00726	0.0174	CcSEcCtD
Propofol—Eye pain—Varenicline—nicotine dependence	0.00679	0.0163	CcSEcCtD
Propofol—Atrial fibrillation—Varenicline—nicotine dependence	0.00647	0.0155	CcSEcCtD
Propofol—Affect lability—Varenicline—nicotine dependence	0.00603	0.0145	CcSEcCtD
Propofol—Urinary retention—Varenicline—nicotine dependence	0.00583	0.014	CcSEcCtD
Propofol—Mood swings—Varenicline—nicotine dependence	0.00581	0.0139	CcSEcCtD
Propofol—FAAH—midbrain—nicotine dependence	0.00578	0.109	CbGeAlD
Propofol—Cramp muscle—Varenicline—nicotine dependence	0.00552	0.0132	CcSEcCtD
Propofol—Hyperglycaemia—Varenicline—nicotine dependence	0.00478	0.0115	CcSEcCtD
Propofol—Depression—Varenicline—nicotine dependence	0.00471	0.0113	CcSEcCtD
Propofol—Acute coronary syndrome—Varenicline—nicotine dependence	0.00466	0.0112	CcSEcCtD
Propofol—Myocardial infarction—Varenicline—nicotine dependence	0.00463	0.0111	CcSEcCtD
Propofol—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00458	0.00916	CbGpPWpGaD
Propofol—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00432	0.00863	CbGpPWpGaD
Propofol—Bradycardia—Varenicline—nicotine dependence	0.00432	0.0104	CcSEcCtD
Propofol—Hallucination—Varenicline—nicotine dependence	0.00422	0.0101	CcSEcCtD
Propofol—UGT1A8—Biological oxidations—CYP2A7—nicotine dependence	0.00416	0.00831	CbGpPWpGaD
Propofol—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00409	0.00818	CbGpPWpGaD
Propofol—Visual impairment—Varenicline—nicotine dependence	0.00409	0.0098	CcSEcCtD
Propofol—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00396	0.00792	CbGpPWpGaD
Propofol—Tinnitus—Varenicline—nicotine dependence	0.00395	0.00948	CcSEcCtD
Propofol—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00395	0.0079	CbGpPWpGaD
Propofol—GABRB2—GABA receptor activation—GABRA4—nicotine dependence	0.00395	0.00789	CbGpPWpGaD
Propofol—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0039	0.00779	CbGpPWpGaD
Propofol—Chills—Varenicline—nicotine dependence	0.00381	0.00913	CcSEcCtD
Propofol—Arrhythmia—Varenicline—nicotine dependence	0.00379	0.00909	CcSEcCtD
Propofol—GABRA2—GABA receptor activation—GABRA4—nicotine dependence	0.0037	0.00739	CbGpPWpGaD
Propofol—Erythema—Varenicline—nicotine dependence	0.00369	0.00886	CcSEcCtD
Propofol—GABRB3—GABA receptor activation—GABRA4—nicotine dependence	0.00368	0.00735	CbGpPWpGaD
Propofol—FAAH—brain—nicotine dependence	0.00363	0.0686	CbGeAlD
Propofol—Dysgeusia—Varenicline—nicotine dependence	0.00362	0.00867	CcSEcCtD
Propofol—GABRG2—GABA receptor activation—GABRA4—nicotine dependence	0.00361	0.00721	CbGpPWpGaD
Propofol—Muscle spasms—Varenicline—nicotine dependence	0.00355	0.00851	CcSEcCtD
Propofol—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00354	0.00707	CbGpPWpGaD
Propofol—Tremor—Varenicline—nicotine dependence	0.00346	0.0083	CcSEcCtD
Propofol—Agitation—Varenicline—nicotine dependence	0.00339	0.00814	CcSEcCtD
Propofol—Angioedema—Varenicline—nicotine dependence	0.00337	0.00809	CcSEcCtD
Propofol—SCN2A—midbrain—nicotine dependence	0.00332	0.0628	CbGeAlD
Propofol—Syncope—Varenicline—nicotine dependence	0.00331	0.00794	CcSEcCtD
Propofol—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00325	0.0065	CbGpPWpGaD
Propofol—Loss of consciousness—Varenicline—nicotine dependence	0.00325	0.00778	CcSEcCtD
Propofol—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00322	0.00644	CbGpPWpGaD
Propofol—Cough—Varenicline—nicotine dependence	0.00322	0.00773	CcSEcCtD
Propofol—UGT1A6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00322	0.00643	CbGpPWpGaD
Propofol—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0032	0.0064	CbGpPWpGaD
Propofol—Convulsion—Varenicline—nicotine dependence	0.0032	0.00767	CcSEcCtD
Propofol—Hypertension—Varenicline—nicotine dependence	0.00319	0.00765	CcSEcCtD
Propofol—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.00316	0.0063	CbGpPWpGaD
Propofol—Chest pain—Varenicline—nicotine dependence	0.00314	0.00754	CcSEcCtD
Propofol—Myalgia—Varenicline—nicotine dependence	0.00314	0.00754	CcSEcCtD
Propofol—Anxiety—Varenicline—nicotine dependence	0.00313	0.00751	CcSEcCtD
Propofol—Dry mouth—Varenicline—nicotine dependence	0.00307	0.00737	CcSEcCtD
Propofol—UGT1A6—Biological oxidations—CYP2A7—nicotine dependence	0.00303	0.00606	CbGpPWpGaD
Propofol—Oedema—Varenicline—nicotine dependence	0.00301	0.00723	CcSEcCtD
Propofol—UGT1A6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00299	0.00598	CbGpPWpGaD
Propofol—Shock—Varenicline—nicotine dependence	0.00296	0.00711	CcSEcCtD
Propofol—Tachycardia—Varenicline—nicotine dependence	0.00294	0.00705	CcSEcCtD
Propofol—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00291	0.00582	CbGpPWpGaD
Propofol—Hyperhidrosis—Varenicline—nicotine dependence	0.00291	0.00699	CcSEcCtD
Propofol—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00288	0.00574	CbGpPWpGaD
Propofol—GABRB2—midbrain—nicotine dependence	0.00282	0.0533	CbGeAlD
Propofol—GABRG2—midbrain—nicotine dependence	0.00282	0.0533	CbGeAlD
Propofol—Hypotension—Varenicline—nicotine dependence	0.00282	0.00675	CcSEcCtD
Propofol—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00276	0.0055	CbGpPWpGaD
Propofol—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00275	0.00658	CcSEcCtD
Propofol—CYP1B1—cardiovascular system—nicotine dependence	0.00274	0.0518	CbGeAlD
Propofol—Insomnia—Varenicline—nicotine dependence	0.00273	0.00654	CcSEcCtD
Propofol—Dyspnoea—Varenicline—nicotine dependence	0.00269	0.00644	CcSEcCtD
Propofol—Somnolence—Varenicline—nicotine dependence	0.00268	0.00643	CcSEcCtD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00265	0.00529	CbGpPWpGaD
Propofol—Fatigue—Varenicline—nicotine dependence	0.0026	0.00623	CcSEcCtD
Propofol—Pain—Varenicline—nicotine dependence	0.00258	0.00618	CcSEcCtD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00251	0.00501	CbGpPWpGaD
Propofol—GABRA1—midbrain—nicotine dependence	0.00249	0.0471	CbGeAlD
Propofol—Feeling abnormal—Varenicline—nicotine dependence	0.00248	0.00596	CcSEcCtD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00248	0.00496	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00247	0.00493	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00242	0.00484	CbGpPWpGaD
Propofol—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00241	0.00481	CbGpPWpGaD
Propofol—Urticaria—Varenicline—nicotine dependence	0.00239	0.00574	CcSEcCtD
Propofol—Body temperature increased—Varenicline—nicotine dependence	0.00238	0.00571	CcSEcCtD
Propofol—Abdominal pain—Varenicline—nicotine dependence	0.00238	0.00571	CcSEcCtD
Propofol—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00238	0.00475	CbGpPWpGaD
Propofol—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00236	0.00472	CbGpPWpGaD
Propofol—SCN4A—brain—nicotine dependence	0.00236	0.0446	CbGeAlD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00235	0.0047	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00234	0.00467	CbGpPWpGaD
Propofol—GABRB2—Orphan transporters—GABRA4—nicotine dependence	0.0023	0.0046	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.0023	0.00459	CbGpPWpGaD
Propofol—GABRB3—midbrain—nicotine dependence	0.00217	0.041	CbGeAlD
Propofol—Asthenia—Varenicline—nicotine dependence	0.00216	0.00519	CcSEcCtD
Propofol—GABRA2—Orphan transporters—GABRA4—nicotine dependence	0.00216	0.00431	CbGpPWpGaD
Propofol—GABRB3—Orphan transporters—GABRA4—nicotine dependence	0.00214	0.00428	CbGpPWpGaD
Propofol—Pruritus—Varenicline—nicotine dependence	0.00213	0.00511	CcSEcCtD
Propofol—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00213	0.00425	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00212	0.00423	CbGpPWpGaD
Propofol—GABRG2—Orphan transporters—GABRA4—nicotine dependence	0.00211	0.00421	CbGpPWpGaD
Propofol—SCN2A—brain—nicotine dependence	0.00209	0.0395	CbGeAlD
Propofol—Diarrhoea—Varenicline—nicotine dependence	0.00206	0.00495	CcSEcCtD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00201	0.00401	CbGpPWpGaD
Propofol—Dizziness—Varenicline—nicotine dependence	0.00199	0.00478	CcSEcCtD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00199	0.00398	CbGpPWpGaD
Propofol—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00195	0.0039	CbGpPWpGaD
Propofol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00194	0.00388	CbGpPWpGaD
Propofol—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00192	0.00383	CbGpPWpGaD
Propofol—Vomiting—Varenicline—nicotine dependence	0.00192	0.0046	CcSEcCtD
Propofol—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0019	0.0038	CbGpPWpGaD
Propofol—Rash—Varenicline—nicotine dependence	0.0019	0.00456	CcSEcCtD
Propofol—Dermatitis—Varenicline—nicotine dependence	0.0019	0.00455	CcSEcCtD
Propofol—Headache—Varenicline—nicotine dependence	0.00189	0.00453	CcSEcCtD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00189	0.00377	CbGpPWpGaD
Propofol—CYP2B6—cardiovascular system—nicotine dependence	0.00188	0.0356	CbGeAlD
Propofol—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00188	0.00375	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00187	0.00373	CbGpPWpGaD
Propofol—CYP2C9—cardiovascular system—nicotine dependence	0.00186	0.0352	CbGeAlD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00185	0.0037	CbGpPWpGaD
Propofol—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.00184	0.00368	CbGpPWpGaD
Propofol—CYP2A6—brain—nicotine dependence	0.00183	0.0347	CbGeAlD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00182	0.00364	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00181	0.00363	CbGpPWpGaD
Propofol—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00181	0.00361	CbGpPWpGaD
Propofol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00179	0.00359	CbGpPWpGaD
Propofol—Nausea—Varenicline—nicotine dependence	0.00179	0.00429	CcSEcCtD
Propofol—GABRB2—brain—nicotine dependence	0.00177	0.0335	CbGeAlD
Propofol—GABRG2—brain—nicotine dependence	0.00177	0.0335	CbGeAlD
Propofol—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00177	0.00354	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00177	0.00353	CbGpPWpGaD
Propofol—CYP2E1—cardiovascular system—nicotine dependence	0.00177	0.0334	CbGeAlD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00176	0.00351	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00174	0.00348	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00173	0.00345	CbGpPWpGaD
Propofol—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.0017	0.0034	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.0017	0.0034	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00169	0.00338	CbGpPWpGaD
Propofol—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00168	0.00335	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00166	0.00332	CbGpPWpGaD
Propofol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00164	0.00329	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00163	0.00326	CbGpPWpGaD
Propofol—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00162	0.00324	CbGpPWpGaD
Propofol—GABRA2—brain—nicotine dependence	0.00162	0.0306	CbGeAlD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00162	0.00324	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00162	0.00323	CbGpPWpGaD
Propofol—GABRB2—Ion channel transport—GABRA4—nicotine dependence	0.00161	0.00323	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00159	0.00318	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00159	0.00318	CbGpPWpGaD
Propofol—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00158	0.00315	CbGpPWpGaD
Propofol—GABRA1—brain—nicotine dependence	0.00157	0.0296	CbGeAlD
Propofol—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00154	0.00308	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—CHRNB3—nicotine dependence	0.00152	0.00305	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00152	0.00303	CbGpPWpGaD
Propofol—GABRA2—Ion channel transport—GABRA4—nicotine dependence	0.00151	0.00302	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00151	0.00301	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00151	0.00301	CbGpPWpGaD
Propofol—GABRB3—Ion channel transport—GABRA4—nicotine dependence	0.0015	0.003	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00148	0.00296	CbGpPWpGaD
Propofol—GABRG2—Ion channel transport—GABRA4—nicotine dependence	0.00148	0.00295	CbGpPWpGaD
Propofol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00147	0.00293	CbGpPWpGaD
Propofol—ALB—brain—nicotine dependence	0.00146	0.0277	CbGeAlD
Propofol—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00145	0.00291	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00145	0.0029	CbGpPWpGaD
Propofol—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00145	0.0029	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—CHRNA6—nicotine dependence	0.00145	0.00289	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—CHRNB3—nicotine dependence	0.00143	0.00286	CbGpPWpGaD
Propofol—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00143	0.00285	CbGpPWpGaD
Propofol—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00143	0.00285	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNB3—nicotine dependence	0.00142	0.00284	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—CHRNB3—nicotine dependence	0.00139	0.00279	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00139	0.00278	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00136	0.00273	CbGpPWpGaD
Propofol—GABRB3—brain—nicotine dependence	0.00136	0.0257	CbGeAlD
Propofol—GABRA2—Neuronal System—CHRNA6—nicotine dependence	0.00136	0.00271	CbGpPWpGaD
Propofol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00135	0.0027	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNA6—nicotine dependence	0.00135	0.00269	CbGpPWpGaD
Propofol—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00135	0.00269	CbGpPWpGaD
Propofol—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00135	0.00269	CbGpPWpGaD
Propofol—CYP1B1—brain—nicotine dependence	0.00134	0.0254	CbGeAlD
Propofol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00134	0.00268	CbGpPWpGaD
Propofol—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00133	0.00266	CbGpPWpGaD
Propofol—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00133	0.00266	CbGpPWpGaD
Propofol—CYP1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00133	0.00266	CbGpPWpGaD
Propofol—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00133	0.00265	CbGpPWpGaD
Propofol—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00133	0.00265	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—CHRNA6—nicotine dependence	0.00132	0.00264	CbGpPWpGaD
Propofol—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00132	0.00264	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00132	0.00263	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00131	0.00261	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00129	0.00258	CbGpPWpGaD
Propofol—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.00129	0.00258	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00128	0.00256	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00128	0.00255	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00127	0.00254	CbGpPWpGaD
Propofol—CYP1B1—Biological oxidations—CYP2A7—nicotine dependence	0.00125	0.00251	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00125	0.00249	CbGpPWpGaD
Propofol—CYP1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00124	0.00247	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00124	0.00247	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00123	0.00245	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00123	0.00245	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.00122	0.00244	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00122	0.00243	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00122	0.00243	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00121	0.00241	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0012	0.00239	CbGpPWpGaD
Propofol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00119	0.00238	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00116	0.00232	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.00116	0.00231	CbGpPWpGaD
Propofol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00114	0.00229	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00114	0.00228	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00113	0.00226	CbGpPWpGaD
Propofol—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00113	0.00226	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00111	0.00222	CbGpPWpGaD
Propofol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00109	0.00219	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00109	0.00218	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00109	0.00217	CbGpPWpGaD
Propofol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00109	0.00217	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00108	0.00216	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00106	0.00212	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00105	0.00211	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00105	0.00211	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00105	0.00209	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—GABRA4—nicotine dependence	0.00105	0.00209	CbGpPWpGaD
Propofol—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00104	0.00207	CbGpPWpGaD
Propofol—CYP2C8—brain—nicotine dependence	0.00103	0.0195	CbGeAlD
Propofol—GABRB2—Neuronal System—CHRNB4—nicotine dependence	0.001	0.002	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000991	0.00198	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000988	0.00197	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000982	0.00196	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—GABRA4—nicotine dependence	0.00098	0.00196	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—GABRA4—nicotine dependence	0.000973	0.00195	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000972	0.00194	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000964	0.00193	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—GABRA4—nicotine dependence	0.000956	0.00191	CbGpPWpGaD
Propofol—CYP1A1—brain—nicotine dependence	0.00095	0.018	CbGeAlD
Propofol—GABRA2—Neuronal System—CHRNB4—nicotine dependence	0.000939	0.00188	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNB4—nicotine dependence	0.000933	0.00186	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—CHRNA5—nicotine dependence	0.000932	0.00186	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000929	0.00186	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000928	0.00185	CbGpPWpGaD
Propofol—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000927	0.00185	CbGpPWpGaD
Propofol—CYP2B6—brain—nicotine dependence	0.000923	0.0174	CbGeAlD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000923	0.00184	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—CHRNB4—nicotine dependence	0.000916	0.00183	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000907	0.00181	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000888	0.00177	CbGpPWpGaD
Propofol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000883	0.00176	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—CHRNA5—nicotine dependence	0.000873	0.00175	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000873	0.00174	CbGpPWpGaD
Propofol—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000871	0.00174	CbGpPWpGaD
Propofol—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000869	0.00174	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNA5—nicotine dependence	0.000868	0.00173	CbGpPWpGaD
Propofol—CYP2E1—brain—nicotine dependence	0.000867	0.0164	CbGeAlD
Propofol—GABRG2—Neuronal System—CHRNA5—nicotine dependence	0.000852	0.0017	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000851	0.0017	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000843	0.00168	CbGpPWpGaD
Propofol—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000837	0.00167	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.000836	0.00167	CbGpPWpGaD
Propofol—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000825	0.00165	CbGpPWpGaD
Propofol—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00082	0.00164	CbGpPWpGaD
Propofol—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00082	0.00164	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000818	0.00163	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000813	0.00162	CbGpPWpGaD
Propofol—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000808	0.00161	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.000801	0.0016	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000798	0.00159	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000792	0.00158	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000792	0.00158	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000773	0.00154	CbGpPWpGaD
Propofol—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000773	0.00154	CbGpPWpGaD
Propofol—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000762	0.00152	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—CHRNA3—nicotine dependence	0.000759	0.00152	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000751	0.0015	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.000745	0.00149	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000743	0.00148	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000738	0.00147	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000725	0.00145	CbGpPWpGaD
Propofol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000716	0.00143	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—CHRNA3—nicotine dependence	0.000712	0.00142	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CYP2A7—nicotine dependence	0.000711	0.00142	CbGpPWpGaD
Propofol—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000708	0.00142	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNA3—nicotine dependence	0.000707	0.00141	CbGpPWpGaD
Propofol—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000699	0.0014	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000698	0.00139	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—CHRNA3—nicotine dependence	0.000695	0.00139	CbGpPWpGaD
Propofol—CYP2D6—brain—nicotine dependence	0.000686	0.013	CbGeAlD
Propofol—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000671	0.00134	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—CHRNB2—nicotine dependence	0.000669	0.00134	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000633	0.00127	CbGpPWpGaD
Propofol—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000632	0.00126	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—CHRNB2—nicotine dependence	0.000627	0.00125	CbGpPWpGaD
Propofol—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000624	0.00125	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNB2—nicotine dependence	0.000623	0.00124	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000617	0.00123	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000612	0.00122	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—CHRNB2—nicotine dependence	0.000611	0.00122	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—CHRNA4—nicotine dependence	0.000607	0.00121	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.000607	0.00121	CbGpPWpGaD
Propofol—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000582	0.00116	CbGpPWpGaD
Propofol—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000577	0.00115	CbGpPWpGaD
Propofol—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000574	0.00115	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—CHRNA4—nicotine dependence	0.000569	0.00114	CbGpPWpGaD
Propofol—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000569	0.00114	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—CHRNA4—nicotine dependence	0.000565	0.00113	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000562	0.00112	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—CHRNA4—nicotine dependence	0.000555	0.00111	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.000534	0.00107	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000527	0.00105	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000523	0.00105	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000523	0.00104	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CYP2A7—nicotine dependence	0.000519	0.00104	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000514	0.00103	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000493	0.000984	CbGpPWpGaD
Propofol—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000486	0.000971	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.000485	0.00097	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000449	0.000898	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000403	0.000806	CbGpPWpGaD
Propofol—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00038	0.00076	CbGpPWpGaD
Propofol—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000375	0.000749	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000291	0.000582	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000257	0.000514	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.00023	0.00046	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.00023	0.00046	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.000215	0.000429	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000177	0.000354	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000143	0.000286	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.00014	0.00028	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000132	0.000264	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000121	0.000242	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP2A7—nicotine dependence	0.00012	0.000241	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000108	0.000216	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP2A7—nicotine dependence	9.94e-05	0.000199	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP2A7—nicotine dependence	9.86e-05	0.000197	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP2A7—nicotine dependence	8.42e-05	0.000168	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP2A7—nicotine dependence	6.5e-05	0.00013	CbGpPWpGaD
